Viswanath Devanarayan

10.9k citations

67 papers · 5.2k indexed · 2 hit papers · h-index 28

Impact in

Endocrine and Autonomic Systems top 0.5%
- Regulation of Appetite and Obesity
Immunology top 1%
- Biosimilars and Bioanalytical Methods

Papers in ⓘ

Statistics and Probability 9
- Statistical Methods in Clinical Trials 6
Geriatrics and Gerontology 4

Co-authors: Mark L. Heiman (3 shared papers)Éric Ravussin (2 shared papers)P. Antonio Tataranni (2 shared papers)Christian Weyer (2 shared papers)Matthias H. Tschöp (1 shared paper)Yu Chen Barrett (3 shared papers)Daniel A. Llano (13 shared papers)Eugen Koren (3 shared papers)
Journals: Alzheimer s & Dementia (9 papers)The AAPS Journal (9 papers)Journal of Pharmaceutical and Biomedical Analysis (4 papers)Alzheimer Disease & Associated Disorders (4 papers)Journal of Immunological Methods (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Viswanath Devanarayan

64 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement 2006 · 504 citations

Peers

Countries citing papers authored by Viswanath Devanarayan

Since Specialization

Citations

This map shows the geographic impact of Viswanath Devanarayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viswanath Devanarayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viswanath Devanarayan more than expected).

Fields of papers citing papers by Viswanath Devanarayan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viswanath Devanarayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viswanath Devanarayan. The network helps show where Viswanath Devanarayan may publish in the future.

Co-authors

The 25 scholars most cited alongside Viswanath Devanarayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Viswanath Devanarayan Line = papers co-authored together Viswanath Devanarayan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Circulating Ghrelin Levels Are Decreased in Human Obesity Diabetes ·Matthias H. Tschöp, Christian Weyer, P. Antonio Tataranni, Viswanath Devanarayan, Éric Ravussin, Mark L. Heiman Hit paper breakdown →	2001	1645
2	Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement Pharmaceutical Research ·Jean W. Lee, Viswanath Devanarayan, Yu Chen Barrett, Russell Weiner, John Allinson, Scott Fountain, Stephen Keller, Ira Weinryb, Marie Green, Larry Duan, James A. Rogers, Robert Millham, Peter J. O’Brien, Jeff M. Sailstad, Masood N. Khan, Chad Ray, John A. Wagner Hit paper breakdown →	2006	504
3	Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products Journal of Immunological Methods ·Anthony R. Mire‐Sluis, Yu Chen Barrett, Viswanath Devanarayan, Eugen Koren, Hank Liu, Mauricio Maia, Thomas Parish, G. H. Scott, Gopi Shankar, Elizabeth W. Shores, Steven J. Swanson, Gary T. Taniguchi, Daniel Wierda, Linda A. Zuckerman	2004	463
4	Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products Journal of Pharmaceutical and Biomedical Analysis ·Gopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, Yu Chen Barrett, Ronald R. Bowsher, Deborah Finco‐Kent, Michele Fiscella, Boris Gorovits, Susan Kirschner, Michael Moxness, Thomas Parish, Valerie Quarmby, Holly W. Smith, Wendell C. Smith, Linda A. Zuckerman, Eugen Koren	2008	444
5	Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations The AAPS Journal ·Ganesh M. Shankar, Steven Arkin, Laurent Cocea, Viswanath Devanarayan, Susan Kirshner, Arno Kromminga, Valerie Quarmby, S Richards, Christian K. Schneider, Meena Subramanyam, Steven J. Swanson, Daniela Verthelyi, Samantha S. Yim	2014	236
6	Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products Journal of Immunological Methods ·Eugen Koren, Holly W. Smith, Elizabeth W. Shores, Gopi Shankar, Deborah Finco‐Kent, Bonita Rup, Yu-Chen Barrett, Viswanath Devanarayan, Boris Gorovits, Shalini Gupta, Thomas Parish, Valerie Quarmby, Michael Moxness, Steven J. Swanson, Gary T. Taniguchi, Linda A. Zuckerman, Christopher Stebbins, Anthony R. Mire‐Sluis	2008	231
7	Ritonavir and saquinavir combination therapy for the treatment of HIV infection AIDS ·D. William Cameron, Anthony J. Japour, Yi Xu, Ann Hsu, John W. Mellors, Charles Farthing, Calvin Cohen, Donald M. Poretz, Martin Markowitz, Steve Follansbee, Jonathan B. Angel, Deborah K. McMahon, David D. Ho, Viswanath Devanarayan, Richard A. Rode, Miklos Salgo, Dale J. Kempf, Richard Granneman, John M. Leonard, Eugene Sun	1999	157
8	Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum Journal of Pharmaceutical and Biomedical Analysis ·Chad Ray, Ronald R. Bowsher, Wendell C. Smith, Viswanath Devanarayan, Mark B. Willey, John T. Brandt, Robert A. Dean	2004	110
9	Confirmatory reanalysis of incurred bioanalytical samples The AAPS Journal ·Mario L. Rocci, Viswanath Devanarayan, David B. Haughey, Paula Jardieu	2007	107
10	Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics Journal of Pharmaceutical and Biomedical Analysis ·Shalini Gupta, Viswanath Devanarayan, Deborah Finco, George R. Gunn, Susan Kirshner, Susan Richards, Bonita Rup, An Song, Meena Subramanyam	2011	89
11	Human SPF45, a Splicing Factor, Has Limited Expression in Normal Tissues, Is Overexpressed in Many Tumors, and Can Confer a Multidrug-Resistant Phenotype to Cells American Journal Of Pathology ·Janardhan Sampath, Pandy R. Long, Robert L. Shepard, Xiaoling Xia, Viswanath Devanarayan, George E. Sandusky, William L. Perry, Anne H. Dantzig, Mark J. Williamson, Mark Rolfe, Robert E. Moore	2003	63
12	Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points The AAPS Journal ·Viswanath Devanarayan, Wendell C. Smith, Rocco L. Brunelle, Mary Seger, Kim Krug, Ronald R. Bowsher	2017	61
13	HTS Assay Validation Philip W. Iversen, Benoît Beck, Yunfei Chen, Walthere Dere, Viswanath Devanarayan, Brian J. Eastwood, Mark W. Farmen, Stephen J. Iturria, Chahrzad Montrose, Roger A. Moore, Jeffrey R. Weidner, G. Sitta Sittampalam	2012	61
14	Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines Molecular Cancer Therapeutics ·Stephen K. Tahir, John Wass, Mary K. Joseph, Viswanath Devanarayan, Paul Hessler, Haichao Zhang, Steve W. Elmore, Paul E. Kroeger, Christin Tse, Saul H. Rosenberg, Mark G. Anderson	2010	59
15	Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge Alzheimer s & Dementia ·Hugo Geerts, Penny A. Dacks, Viswanath Devanarayan, Magali Haas, Zaven S. Khachaturian, Mark Forrest Gordon, Stuart Maudsley, Klaus Romero, Diane Stephenson, (unknown)	2016	58
16	Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Alzheimer Disease & Associated Disorders ·Daniel A. Llano, Viswanath Devanarayan, Adam J. Simon	2012	58
17	Derivation of a New ADAS-cog Composite Using Tree-based Multivariate Analysis Alzheimer Disease & Associated Disorders ·Daniel A. Llano, Genevieve Laforet, Viswanath Devanarayan	2010	56
18	Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development The AAPS Journal ·Darshana Jani, John Allinson, Flora Berisha, Kyra J. Cowan, Viswanath Devanarayan, Carol Gleason, Andreas Jeromin, Steve Keller, Masood U Khan, Bill Nowatzke, Paul Rhyne, Laurie Stephen	2015	54
19	Empirical simulation extrapolation for measurement error models with replicate measurements Statistics & Probability Letters ·Viswanath Devanarayan, Leonard A. Stefanski	2002	46
20	Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls Alzheimer Disease & Associated Disorders ·Daniel A. Llano, Jinhe Li, Jeffrey F. Waring, Teresa A. Ellis, Viswanath Devanarayan, David G. Witte, Robert Lenz	2011	44

About Viswanath Devanarayan

Viswanath Devanarayan is a scholar working on Statistics and Probability, Geriatrics and Gerontology, Psychiatry and Mental health, Immunology and Physiology, having authored 67 papers that have together received 5.2k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (19 papers), Dementia and Cognitive Impairment Research (14 papers), Alzheimer's disease research and treatments (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Biosensing Techniques and Applications (8 papers), Computational Drug Discovery Methods (7 papers), Statistical Methods in Clinical Trials (6 papers) and Protein purification and stability (5 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.4k citations), Immunology (1.6k citations), Nutrition and Dietetics (916 citations), Physiology (1.4k citations) and Radiology, Nuclear Medicine and Imaging (1.1k citations). Viswanath Devanarayan has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Mark L. Heiman, Éric Ravussin, P. Antonio Tataranni, Christian Weyer, Matthias H. Tschöp, Yu Chen Barrett, Daniel A. Llano, Eugen Koren, Gopi Shankar and Linda A. Zuckerman. Their work appears in journals such as Alzheimer s & Dementia, The AAPS Journal, Journal of Pharmaceutical and Biomedical Analysis, Alzheimer Disease & Associated Disorders and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact